| | Platelet Activating Factor (PAF) Receptor Agonists and Antagonists
- 1-O-Hexadecyl-2-acetyl-sn-glycero-3-phospho-(N,N,N-trimethyl)-hexanolamine
PAF antagonist. Shows inhibitory behavior on platelet aggregation, secretion and phospholipid turnover.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-202862 | 99103-16-9 | C30H62NO7P | 5 mg/25 mg |
- Araguspongin B
Products isolated from Pacific basin sponges with notable vasodilatory properties. Serve as important signal transduction messengers acting to promote transfer of Ca2+ from intracellular stores. Shown to exhibit an antagonizing effect of the calcium-releasing action of inosital 1,4,5-triphosphate at receptor levels in cerebral microsomes.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-205215 | 123000-02-2 | C28H50N2O2 | 100 µg/250 µg |
- Bis(methylthio)gliotoxin (FR-49175)
Analog of gliotoxin shown to inhibit PAF-induced platelet aggregation and speed up PAF hydrolysis.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201027 | 74149-38-5 | C15H20N2O4S2 | 1 mg/5 mg |
- C-PAF (Carbamyl-PAF )
C-PAF (Carbamyl-PAF) is utilized as a non-hydrolyzable bioactive analog of PAF.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201025 | 91575-58-5 | C26H55N2O7P | 5 mg/25 mg |
- (±) cis-2,5-Bis(3,4,5-trimethoxyphenyl)-1,3-dioxolane
Inactive enantiomer of (±) trans-2,5-Bis(3,4,5-trimethoxyphenyl)-1,3-dioxolane, a PAFr inhibitor. Useful as a negative control.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201031 | 116673-47-3 | C21H26O8 | 1 mg/5 mg |
- CV-3988
A specific antagonist of PAF binding to the PAF receptor. Inhibits PAF-induced platelet aggregation.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201015 | 85703-73-7 | C28H53N2O7PS | 5 mg/25 mg |
- Eptifibatide
A selective inhibitor of platelet glycoprotein IIb/IIIa receptors.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-205675 | 148031-34-9 | C35H49N11O9S2 | 5 mg/10 mg |
- ET-18-OCH3
An ether lipid analogue that induces selective apoptosis in tumor cells without affecting normal cells. Agent has ability activate intracellular Fas/CD95 and inhibit activation of p70S6K.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201021 | 77286-66-9 | C27H58NO6P | 5 mg/25 mg |
- Ginkgolide B (BN 52021)
Most potent member of ginkgolide family of PAF antagonists. Has been found to accelerate PAF hydrolysis by promoting PAF-AH I α2 homodimer activity. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201037 | 15291-77-7 | C20H24O10 | 10 mg/50 mg |
- PCA 4248
A dihydropyridine that inhibits PAF in a competitive manner at the PAF receptor level. Shown to also reduce serotonin secretion caused by PAF.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-203446 | 123875-01-4 | C19H23NO4S | 10 mg/50 mg |
- Octylonium Bromide
Reported to antagonize platelet-activating factor induced aggregation of rabbit platelet-rich plasma. Demonstrates the ability to potently block neuronal nicotinic acetylcholine receptors.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201035 | 26095-59-0 | C29H43N2O4Br | 5 mg/25 mg |
- (±) trans-2,5-Bis(3,4,5-trimethoxyphenyl)-1,3-dioxolane
(±) trans-2,5-Bis(3,4,5-trimethoxyphenyl)-1,3-dioxolane is a selective and potent platelet activating factor (PAF) antagonist of the diaryl tetrahydrofuran class. Reported to block LTP in field CA1 in rat hippocamp| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201029 | 116673-45-1 | C21H26O8 | 1 mg/5 mg |
- WEB-2086
WEB-2086 (Apafant) is a Platelet Activating Factor (PAF) receptor antagonist shown to have anticancer and cell differentiation effects.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201007 | 105219-56-5 | C22H22ClN5O2S | 1 mg/5 mg |
|